Russell Investments Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Sell |
2,514
-127,224
| -98% | -$1.45M | ﹤0.01% | 3116 |
|
|
2025
Q1 | $1.54M | Buy |
129,738
+93,993
| +263% | +$1.12M | ﹤0.01% | 1845 |
|
|
2024
Q4 | $673K | Buy |
35,745
+35,017
| +4,810% | +$660K | ﹤0.01% | 2173 |
|
|
2024
Q3 | $16.4K | Sell |
728
-2,745
| -79% | -$61.7K | ﹤0.01% | 2998 |
|
|
2024
Q2 | $72.5K | Sell |
3,473
-50,069
| -94% | -$1.04M | ﹤0.01% | 2694 |
|
|
2024
Q1 | $787K | Buy |
53,542
+23,044
| +76% | +$339K | ﹤0.01% | 2060 |
|
|
2023
Q4 | $315K | Buy |
30,498
+15
| +0% | +$155 | ﹤0.01% | 2337 |
|
|
2023
Q3 | $240K | Sell |
30,483
-5,073
| -14% | -$39.9K | ﹤0.01% | 2454 |
|
|
2023
Q2 | $355K | Sell |
35,556
-1,120
| -3% | -$11.2K | ﹤0.01% | 2329 |
|
|
2023
Q1 | $326K | Buy |
36,676
+12,587
| +52% | +$112K | ﹤0.01% | 2381 |
|
|
2022
Q4 | $264K | Buy |
24,089
+23,210
| +2,641% | +$255K | ﹤0.01% | 2500 |
|
|
2022
Q3 | $11K | Buy |
+879
| New | +$11K | ﹤0.01% | 2856 |
|
|
2021
Q3 | – | Sell |
-5,749
| Closed | -$152K | – | 3160 |
|
|
2021
Q2 | $152K | Hold |
5,749
| – | – | ﹤0.01% | 2976 |
|
|
2021
Q1 | $178K | Buy |
+5,749
| New | +$178K | ﹤0.01% | 2861 |
|